Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crescent Biopharma Inc (CBIO)

Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Crescent Biopharma Inc 300 FIFTH AVENUE WALTHAM MA 02451 USA

www.crescentbiopharma.com Employees: 4 P: 617-430-5595

Sector:

Medical

Description:

Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors. Crescent Biopharma, formerly known as GlycoMimetics Inc., is based in ROCKVILLE, Md.

Key Statistics

Overview:

Market Capitalization, $K 175,468
Enterprise Value, $K 164,748
Shares Outstanding, K 13,893
Float, K 13,337
% Float 96.00%
Short Interest, K 794
Short Float 5.72%
Days to Cover 2.49
Short Volume Ratio 0.47
% of Insider Shareholders 4.00%
% of Institutional Shareholders 75.19%
Annual Net Income, $ -37,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,610 K
EBIT, $ -56,650 K
EBITDA, $ -56,610 K
3-Year Return -95.07%
5-Year Return -96.75%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 63.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.27 on 11/06/25
Next Earnings Date 02/12/26
Earnings Per Share ttm -21.20
EPS Growth vs. Prev Qtr 74.24%
EPS Growth vs. Prev Year 91.53%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 08/20/15
Dividend Payable Date 08/19/15
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 06/16/25

CBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -87.24%
Return-on-Assets % -71.57%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.92
Book Value/Share 5.97
Interest Coverage -0.47
60-Month Beta 1.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar